CSIMarket
 
Generex Biotechnology Corp  (GNBT)
Other Ticker:  
 
 



EARNINGS REPORT by CSIMarket

Redemption of Losses, Topline Tumbles

Generex Biotechnology Corp announced financial period ending Apr 30 2021 operating deficit of $-6.363455 millions

pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_CommonsFor the financial period ending Apr 30 2021 Generex Biotechnology Corp decreased loss of $-0.04 per share compare to $-0.07 a year ago and improved from $-0.22 per share from the preceding quarter.

Sales fell sharply to $0 millions from $0 millions in the same quarter a year ago and sequentially from $0 millions.



Company achieved net income of $8.485 millions in the financial period ending Apr 30 2021 an improvement versus a net loss of $-5.492 millions in the same quarter a year ago.


Generex Biotechnology Corp is expected to report next financial results on March 16, 2022.


    Recently Reported Results
Hot_seat_By_Lian_Chang_(originally_posted_to_Flickr_as_Hot_seat)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Zhrh Corp

Break-even but Revenues Unchanged

For the financial period ending Apr 30 2021 Generex Biotechnology Corp decreased loss of $-0.04 per share compare to $-0.07 a year ago and improved from $-0.22 per share from the preceding quarter.

Sales fell sharply to $0 millions from $0 millions in the same quarter a year ago and sequentially from $0 millions.

Zhrh Corp reported operating shortfall of $-0.001516 millions, in the fiscal time frame ending Jun 30 2020, an improvement from the operating shortfall of $-0.015411 millions, realized in fourth quarter of 2019
Zhrh Corp reported net loss of $-0.01 millions and Sales of $0.00 millions for the fiscal year 2020.

Company reported break-even compared to $0.00 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.

KTDR stock quotes, charts, profile

Growth Rates, Profitability, PE

pumping-gas Producer Price Index

Producer prices continued to grow

U.S. Wholesale prices continued to rise in July, adding to inflationary worries.

Reel-Film-Entertainment-Cinema-Movie-Projector-1673022 Manchester United Plc

Losses Widen, Sales Down Slightly

Weakening demand led to deficit in the fourth quarter of 2021 earnings season, Sales fell by -2.93% to $494.12 millions and loss per share was at $-0.57 compared to $-0.14 per share realized in quarter a year ago.

From the preceding quarter, from $0.00 per share and from $0.00 millions.
Manchester United Plc reported net loss of $-92.22 millions and Sales of $494.12 millions for the fiscal year 2021.

Net loss per share has widen to $-0.57 from $-0.14 in previous fiscal year, while Sales decreased by -2.93 % from $509.04 millions a year ago.

MANU stock quotes, charts, profile

Growth Rates, Profitability, PE

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Benitec Biopharma Inc

Deficit Bigger Than a Year Ago, Topline Tumbles

Benitec Biopharma Inc reported disastrous fourth quarter of 2021, where Sales faded to $0.00 millions and loss per share has widen to $-0.57, from the same quarter a year ago.

increased from the preceding quarter from $-0.82 per share, from $0.00 millions.
Benitec Biopharma Inc reported net loss of $-13.88 millions and Sales of $0.06 millions for the fiscal year 2021.

Company has decreased loss per share to $-3.23 from $-8.10 in the previous fiscal year, while Sales Tumbled by -42.16 % from $0.10 millions a year ago.

BNTC stock quotes, charts, profile

Growth Rates, Profitability, PE

2937157436_007c50dfe0_z Jialijia Group Corp Ltd

Losses Widen but Revenues Unchanged

In the most recent fiscal period Jialijia Group Corp Ltd increased losses of $-0.10 per share compared to $-0.05 a year ago and increased losses from $-0.03 per share from the previous quarter.

Jialijia Group Corp Ltd reported operating loss of $-0.062453 millions, in the most recent fiscal period, a deterioration from the operating shortfall of $-0.03022 millions, realized in second quarter of 2020

RZZN stock quotes, charts, profile

Growth Rates, Profitability, PE

house-1525913_960_720 Housing Starts

July U.S. housing starts fell by -7.0 %

Housing starts decreased in July following the decline in building permits in previous month, following gain in previous period.

Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Durable Goods Orders

Durable goods orders down -0.14 %


Factory Orders (Picture Autor: Wolfgang Meinhart) licence GNU Factory Orders

Durable Goods orders returned to Growth

Bookings grew again after stagnation in the last month, due to increase in primary metals bookings.

dna-163466__340 China Health Industries Holdings Inc

Break-even, Topline Tumbles

In the fourth quarter of 2021 China Health Industries Holdings Inc reached break-even of $-0.00 per share compared to $0.01 a year ago and from $0.00 per share from the previous quarter.

Sales fell sharply by -78.73% to $0.43 millions from $2.03 millions in the same quarter a year ago and sequentially Sales Tumbled by -44.49% from $0.78 millions.
In the fiscal year 2021, China Health Industries Holdings Inc reported Sales of $6.49 millions and net income of $1.29 millions.

Income per share faded by -63.65 % to $0.02 per share from $0.05 in the previous fiscal year, while Sales Tumbled by -34.63 % from $9.93 millions a year ago.

CHHE stock quotes, charts, profile

Growth Rates, Profitability, PE

Interior_pd Us Nuclear Corp

Us Nuclear Corp announced financial period ending Jun 30 2021 operating shortfall of $-0.464998 millions

In the financial period ending Jun 30 2021 Us Nuclear Corp increased losses of $-0.05 per share compared to $-0.01 a year ago and increased losses from $-0.03 per share from the previous quarter.

Sales grew in double digits by 16.66% to $0.35 millions from $0.30 millions in the same quarter a year ago and sequentially Sales fell by -15.62% from $0.42 millions.

UCLE stock quotes, charts, profile

Growth Rates, Profitability, PE

tablet_By_Bin_im_Garten_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Duesenberg Technologies Inc

Company Fail to Break-even Despite Surge in Sales

Company loss increased at $-0.01 per share in the third quarter of 2021, although its Sales surged by 44.18% to $0.01 millions from the same quarter a year ago.

In the previous quarter company realized Sales of $0.01 millions and $-0.01 per share.

VGRBF stock quotes, charts, profile

Growth Rates, Profitability, PE

Sandwiches_Vienna_By_Jebulon_(Own_work)_[CC0],_via_Wikimedia_Commons Natural Alternatives International Inc

Natural Alternatives International Inc announced fourth quarter of 2021 operating income of $3.495 millions

Natural Alternatives International Inc announced earnings per share of $0.47 and Sales of $46.32 millions in the fourth quarter of 2021, Company's earnings turn positive per share, versus $-0.66 eps, earned in the same quarter a year ago, although Natural Alternatives International Inc saw its Sales rise by 76.69% in the same period.

In contrast to the third quarter Sales decreased by -4.16% from $46.32 millions and eps soared by 56.35 % from $0.30 per share.
Natural Alternatives International Inc reported earnings of $10.77 millions and Sales of $178.52 millions for the fiscal year 2021.

Company reported earnings per share of $1.69 compared to $-0.25 in the previous fiscal year, while Sales surged by 50.17 % from $118.88 millions a year ago.

NAII stock quotes, charts, profile

Growth Rates, Profitability, PE

business-idea-2988085_960_720.jpg Gex Management Inc

Gex Management Inc announced second quarter of 2021 operating shortfall of $-0.175893 millions

In the second quarter of 2021 Gex Management Inc reached break-even of $-0.00 per share compared to $-0.00 a year ago and from $-0.01 per share from the previous quarter.

Sales increased sharply by 256.28% to $0.38 millions from $0.11 millions in the same quarter a year ago and sequentially Sales doubled by 121.19 % from $0.17 millions.

GXXM stock quotes, charts, profile

Growth Rates, Profitability, PE

Mobilfunkantennenanlage_Niwre_at_the_German_language_Wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common George Risk Industries Inc

Despite Very Strong Sales EPS Fell

George Risk Industries Inc announced earnings per share of $0.35 and Sales of $5.18 millions in the first quarter of 2021, Company's income dropped by -30% per share, versus $0.50 eps, earned in the same quarter a year ago, although George Risk Industries Inc saw its Sales rise by 22.44% in the same period.

Sequentially profit plummeted by -42.49% from $0.61 per share and Sales decreased by -4.31% from $5.18 millions.

RSKIA stock quotes, charts, profile

Growth Rates, Profitability, PE



Other GNBT's Earnings Reports

Generex Biotechnology reported second quarter 2020 earnings

Generex Biotechnology reported first quarter 2020 earnings

Generex Biotechnology reported fourth quarter 2020 earnings

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PRPC's Profile

Stock Price

PRPC's Financials

Business Description

Fundamentals

Charts & Quotes

PRPC's News

Suppliers

PRPC's Competitors

Customers & Markets

Economic Indicators

PRPC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071